BARDA seeks info on Phase 2+ antifungals for Candida and Aspergillus Dear All: As discussed in prior newsletters, BARDA is constantly working to ensure it has adequate medical countermeasures (MCMs) for a variety of possible threats. Read More » 22 May 2026 No Comments